Stojanović M, Bursać D. Immunotoxicity of Pembrolizumab in patients with metastatic non-small cell lung cancer: A single-centre study. Arch Oncol [Internet]. 2024 Aug. 13 [cited 2026 Jul. 12];30(1):14-8. Available from: https://asistent.ceon.rs/index.php/aoo/article/view/49638